POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 67 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,709 | +35.2% | 28,029 | 0.0% | 0.00% | – |
| Q2 2023 | $49,331 | -3.3% | 28,029 | +145.1% | 0.00% | – |
| Q1 2022 | $51,000 | -34.6% | 11,437 | 0.0% | 0.00% | – |
| Q4 2021 | $78,000 | -22.8% | 11,437 | -17.2% | 0.00% | – |
| Q3 2021 | $101,000 | -91.1% | 13,813 | -87.9% | 0.00% | -100.0% |
| Q2 2021 | $1,139,000 | +2.0% | 113,737 | -2.8% | 0.00% | 0.0% |
| Q1 2021 | $1,117,000 | -59.8% | 117,036 | -53.8% | 0.00% | -66.7% |
| Q4 2020 | $2,777,000 | +13.0% | 253,160 | -8.6% | 0.01% | +20.0% |
| Q3 2020 | $2,458,000 | – | 276,976 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
| Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
| Atom Investors LP | 156,168 | $371,680 | 0.08% |
| Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
| Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
| Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
| XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
| Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
| RBF Capital, LLC | 70,171 | $167,007 | 0.01% |